ByTrending Posts
Can AI Turn Biobank Data into Precision Drug…
Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences, and Sapien Biosciences,…
How Will Axxam and Molecular Health’s AI-Powered Alliance…
Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health and Axxam have…
Can Clairity’s FDA-Approved AI Breast Cancer Prediction Tool…
Key Highlights: AI-Driven Risk Prediction: A Breakthrough in Preventive OncologyBoston-based Clairity received FDA de novo authorization for Clairity…
MedInvest 2025: How NeuroOne’s AI-Enabled Brain Stimulation and…
Key Highlights: 1. NeuroOne’s Vision: AI for Real-World Neurological DisordersNeuroOne will join MedInvest’s MedTech, AI & Digital Health…
How CareCloud Is Applying AI to Transform Clinical…
Key Highlights CareCloud to Join Elite Healthcare IT Panel at Maxim ConferenceCareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading…
How Insilico’s AI-Discovered Drug Achieved a Landmark Clinical…
Key Highlights:• Insilico Medicine’s AI-driven drug discovery platform Pharma.AI enabled rapid development of Rentosertib, a novel TNIK inhibitor…
Can VUMC’s New AI Technologies Reshape Cancer Diagnostics…
Key Highlights AI-Powered MSI-SEER Revolutionizes Tumor ProfilingVanderbilt University Medical Center (VUMC), in collaboration with Mayo Clinic and leading…
How Carterra, Pfizer, and GSK Are Scaling AI…
Key Highlights AI at the Core of the Next Drug Discovery WaveCarterra Inc., a front-runner in high-throughput biology,…
How Is Caltech’s AI Smart Bandage Set to…
Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…
Trending Posts
Latest Stories
Is Insilico Medicine Redefining Drug Discovery as AI Becomes Core to Biopharma Strategy?
Executive Summary Insilico Medicine has emerged as one of the most influential AI-native biotechnology companies,…
Can Vanda Pharma’s FDA Approval of Nereus Unlock a New Growth Chapter in Motion-Sickness Treatment?
New York | Jan, 2026 — Vanda Pharmaceuticals Inc. achieved a major regulatory and commercial…
Can Bristol Myers Squibb’s $330 Million AI Investment in 2025 — Powered by Strategic Partnerships — Accelerate Discovery, R&D and Commercial Impact in 2026?
Global – December 31, 2025 — Bristol Myers Squibb (BMS) significantly expanded its commitment to…
Can GSK’s $340 Million AI Investment in 2025 — Backed by Strategic Collaborations — Accelerate Discovery, R&D and Commercial Growth in 2026?
Global – December 31, 2025 — GlaxoSmithKline plc (GSK) significantly expanded its use of artificial…
Gallery
